
Sign up to save your podcasts
Or


Nvidia buys chipmaker Arm Holdings in a deal worth $40 billion. Oracle becomes TikTok’s technology partner in the U.S. Gilead Sciences buys cancer treatment-maker Immunomedics for $21 billion. Bill Barker analyzes those stories and discusses the NFL’s opening weekend and AB-InBev cutting in-stadium sponsorships.
By The Motley Fool4.7
16041,604 ratings
Nvidia buys chipmaker Arm Holdings in a deal worth $40 billion. Oracle becomes TikTok’s technology partner in the U.S. Gilead Sciences buys cancer treatment-maker Immunomedics for $21 billion. Bill Barker analyzes those stories and discusses the NFL’s opening weekend and AB-InBev cutting in-stadium sponsorships.

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners